0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Plasma Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-35R2324
Home | Market Reports | Health| Nursing
Global Plasma Therapy Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Plasma Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-35R2324
Report
September 2022
114 Pages
QYResearch
Region: Global, Europe, North America
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Plasma Therapy market is projected to reach US$ 532.6 million by 2028 from an estimated US$ 300.6 million in 2022, at a CAGR of 10.0% during 2023 and 2028.

North America is the largest consumption place, with a consumption market share nearly 53% . Europe is the second largest consumption place with the consumption market share of 26%. Terumo, Arthrex, Zimmer Biomet, DePuy Synthes and EmCyte are the leaders of the industry, top 3 companies occupied about 55% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Plasma Therapy.
The Plasma Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Plasma Therapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics
Product Type Insights
Global markets are presented by Plasma Therapy type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Plasma Therapy are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Plasma Therapy Segment by Type

Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Plasma Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Plasma Therapy market.

Plasma Therapy Segment by Application

Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Plasma Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Plasma Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Plasma Therapy industry.
This report helps stakeholders to gain insights into which regions to target globally.
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Therapy.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

1 Study Coverage
1.1 Plasma Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Plasma Therapy Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Pure PRP
1.2.3 Leucocyte-rich PRP
1.2.4 Leukocyte-rich Fibrin (L-PRF)
1.3 Market by Application
1.3.1 Global Plasma Therapy Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Orthopedic
1.3.3 Darmatology
1.3.4 Cardiac Muscle Injury
1.3.5 Dental
1.3.6 Nerve Injury
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Plasma Therapy Market Size Estimates and Forecasts
2.2 Plasma Therapy Market Size by Region: 2022 Versus 2028
2.2.1 Global Plasma Therapy Revenue by Region: 2017-2022
2.2.2 Global Plasma Therapy Revenue Forecast by Region (2023-2028)
2.2.3 Global Plasma Therapy Revenue Market Share by Region (2017-2028)
3 Global Plasma Therapy by Company
3.1 Global Plasma Therapy Revenue by Company (2017-2022)
3.2 Global Plasma Therapy Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Plasma Therapy Companies around the World: Ranking by Revenue
3.3.2 Global Plasma Therapy Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Plasma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Plasma Therapy Companies Headquarters & Product Type
3.4.1 Plasma Therapy Companies Headquarters
3.4.2 Global Plasma Therapy Companies Product & Service
3.4.3 Date of International Companies Enter into Plasma Therapy Market
3.5 Global Plasma Therapy Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Terumo
4.1.1 Terumo Corporation Information
4.1.2 Terumo Description, Business Overview
4.1.3 Terumo Plasma Therapy Products Offered
4.1.4 Terumo Plasma Therapy Revenue and Gross Margin (2017-2022)
4.1.5 Terumo Plasma Therapy Revenue by Product in 2021
4.1.6 Terumo Plasma Therapy Revenue by Application in 2021
4.1.7 Terumo Plasma Therapy Revenue by Geographic Area in 2021
4.1.8 Terumo Recent Developments
4.2 Arthrex
4.2.1 Arthrex Corporation Information
4.2.2 Arthrex Description, Business Overview
4.2.3 Arthrex Plasma Therapy Products Offered
4.2.4 Arthrex Plasma Therapy Revenue and Gross Margin (2017-2022)
4.2.5 Arthrex Plasma Therapy Revenue by Product in 2021
4.2.6 Arthrex Plasma Therapy Revenue by Application in 2021
4.2.7 Arthrex Plasma Therapy Revenue by Geographic Area in 2021
4.2.8 Arthrex Recent Developments
4.3 Zimmer Biomet
4.3.1 Zimmer Biomet Corporation Information
4.3.2 Zimmer Biomet Description, Business Overview
4.3.3 Zimmer Biomet Plasma Therapy Products Offered
4.3.4 Zimmer Biomet Plasma Therapy Revenue and Gross Margin (2017-2022)
4.3.5 Zimmer Biomet Plasma Therapy Revenue by Product in 2021
4.3.6 Zimmer Biomet Plasma Therapy Revenue by Application in 2021
4.3.7 Zimmer Biomet Plasma Therapy Revenue by Geographic Area in 2021
4.3.8 Zimmer Biomet Recent Developments
4.4 DePuy Synthes
4.4.1 DePuy Synthes Corporation Information
4.4.2 DePuy Synthes Description, Business Overview
4.4.3 DePuy Synthes Plasma Therapy Products Offered
4.4.4 DePuy Synthes Plasma Therapy Revenue and Gross Margin (2017-2022)
4.4.5 DePuy Synthes Plasma Therapy Revenue by Product in 2021
4.4.6 DePuy Synthes Plasma Therapy Revenue by Application in 2021
4.4.7 DePuy Synthes Plasma Therapy Revenue by Geographic Area in 2021
4.4.8 DePuy Synthes Recent Developments
4.5 EmCyte
4.5.1 EmCyte Corporation Information
4.5.2 EmCyte Description, Business Overview
4.5.3 EmCyte Plasma Therapy Products Offered
4.5.4 EmCyte Plasma Therapy Revenue and Gross Margin (2017-2022)
4.5.5 EmCyte Plasma Therapy Revenue by Product in 2021
4.5.6 EmCyte Plasma Therapy Revenue by Application in 2021
4.5.7 EmCyte Plasma Therapy Revenue by Geographic Area in 2021
4.5.8 EmCyte Recent Developments
4.6 Regen Lab
4.6.1 Regen Lab Corporation Information
4.6.2 Regen Lab Description, Business Overview
4.6.3 Regen Lab Plasma Therapy Products Offered
4.6.4 Regen Lab Plasma Therapy Revenue and Gross Margin (2017-2022)
4.6.5 Regen Lab Plasma Therapy Revenue by Product in 2021
4.6.6 Regen Lab Plasma Therapy Revenue by Application in 2021
4.6.7 Regen Lab Plasma Therapy Revenue by Geographic Area in 2021
4.6.8 Regen Lab Recent Development
4.7 ISTO Biologics
4.7.1 ISTO Biologics Corporation Information
4.7.2 ISTO Biologics Description, Business Overview
4.7.3 ISTO Biologics Plasma Therapy Products Offered
4.7.4 ISTO Biologics Plasma Therapy Revenue and Gross Margin (2017-2022)
4.7.5 ISTO Biologics Plasma Therapy Revenue by Product in 2021
4.7.6 ISTO Biologics Plasma Therapy Revenue by Application in 2021
4.7.7 ISTO Biologics Plasma Therapy Revenue by Geographic Area in 2021
4.7.8 ISTO Biologics Recent Development
4.8 Cesca Therapeutics
4.8.1 Cesca Therapeutics Corporation Information
4.8.2 Cesca Therapeutics Description, Business Overview
4.8.3 Cesca Therapeutics Plasma Therapy Products Offered
4.8.4 Cesca Therapeutics Plasma Therapy Revenue and Gross Margin (2017-2022)
4.8.5 Cesca Therapeutics Plasma Therapy Revenue by Product in 2021
4.8.6 Cesca Therapeutics Plasma Therapy Revenue by Application in 2021
4.8.7 Cesca Therapeutics Plasma Therapy Revenue by Geographic Area in 2021
4.8.8 Cesca Therapeutics Recent Development
4.9 Weigao
4.9.1 Weigao Corporation Information
4.9.2 Weigao Description, Business Overview
4.9.3 Weigao Plasma Therapy Products Offered
4.9.4 Weigao Plasma Therapy Revenue and Gross Margin (2017-2022)
4.9.5 Weigao Plasma Therapy Revenue by Product in 2021
4.9.6 Weigao Plasma Therapy Revenue by Application in 2021
4.9.7 Weigao Plasma Therapy Revenue by Geographic Area in 2021
4.9.8 Weigao Recent Development
4.10 REV-MED
4.10.1 REV-MED Corporation Information
4.10.2 REV-MED Description, Business Overview
4.10.3 REV-MED Plasma Therapy Products Offered
4.10.4 REV-MED Plasma Therapy Revenue and Gross Margin (2017-2022)
4.10.5 REV-MED Plasma Therapy Revenue by Product in 2021
4.10.6 REV-MED Plasma Therapy Revenue by Application in 2021
4.10.7 REV-MED Plasma Therapy Revenue by Geographic Area in 2021
4.10.8 REV-MED Recent Development
4.11 Nuo Therapeutics
4.11.1 Nuo Therapeutics Corporation Information
4.11.2 Nuo Therapeutics Description, Business Overview
4.11.3 Nuo Therapeutics Plasma Therapy Products Offered
4.11.4 Nuo Therapeutics Plasma Therapy Revenue and Gross Margin (2017-2022)
4.11.5 Nuo Therapeutics Plasma Therapy Revenue by Product in 2021
4.11.6 Nuo Therapeutics Plasma Therapy Revenue by Application in 2021
4.11.7 Nuo Therapeutics Plasma Therapy Revenue by Geographic Area in 2021
4.11.8 Nuo Therapeutics Recent Development
5 Breakdown Data by Type
5.1 Global Plasma Therapy Revenue by Type (2017-2022)
5.2 Global Plasma Therapy Revenue Forecast by Type (2023-2028)
5.3 Plasma Therapy Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Plasma Therapy Revenue by Application (2017-2022)
6.2 Global Plasma Therapy Revenue Forecast by Application (2023-2028)
6.3 Plasma Therapy Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Plasma Therapy Market Size YoY Growth 2017-2028
7.2 North America Plasma Therapy Market Facts & Figures by Country (2017-2028)
7.3 North America Plasma Therapy Revenue by Type (2017-2022)
7.4 North America Plasma Therapy Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Plasma Therapy Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Plasma Therapy Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Plasma Therapy Revenue by Type (2017-2022)
8.4 Asia-Pacific Plasma Therapy Revenue by Application (2017-2022)
9 Europe
9.1 Europe Plasma Therapy Market Size YoY Growth 2017-2028
9.2 Europe Plasma Therapy Market Facts & Figures by Country (2017-2028)
9.3 Europe Plasma Therapy Revenue by Type (2017-2022)
9.4 Europe Plasma Therapy Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Plasma Therapy Market Size YoY Growth 2017-2028
10.2 Latin America Plasma Therapy Market Facts & Figures by Country (2017-2028)
10.3 Latin America Plasma Therapy Revenue by Type (2017-2022)
10.4 Latin America Plasma Therapy Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Plasma Therapy Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Plasma Therapy Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Plasma Therapy Revenue by Type (2017-2022)
11.4 Middle East and Africa Plasma Therapy Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Plasma Therapy Supply Chain Analysis
12.2 Plasma Therapy Key Raw Materials and Upstream Suppliers
12.3 Plasma Therapy Clients Analysis
12.4 Plasma Therapy Sales Channel and Sales Model Analysis
12.4.1 Plasma Therapy Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Plasma Therapy Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Plasma Therapy Distributors
13 Market Dynamics
13.1 Plasma Therapy Industry Trends
13.2 Plasma Therapy Market Drivers
13.3 Plasma Therapy Market Challenges
13.4 Plasma Therapy Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Plasma Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Companies of Pure PRP
    Table 3. Major Companies of Leucocyte-rich PRP
    Table 4. Major Companies of Leukocyte-rich Fibrin (L-PRF)
    Table 5. Global Plasma Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Plasma Therapy Market Size by Region (US$ Million): 2022 VS 2028
    Table 7. Global Plasma Therapy Revenue by Region (2017-2022) & (US$ Million)
    Table 8. Global Plasma Therapy Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 9. Plasma Therapy Revenue by Company (2017-2022) & (US$ Million)
    Table 10. Plasma Therapy Revenue Share by Company (2017-2022)
    Table 11. Ranking of Global Top Plasma Therapy Players by Revenue (US$ Million) in 2021
    Table 12. Global Plasma Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 13. Global Plasma Therapy by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Plasma Therapy as of 2021)
    Table 14. Global Plasma Therapy Companies Headquarters
    Table 15. Global Plasma Therapy Companies Product & Service
    Table 16. Date of International Companies Enter into Plasma Therapy Market
    Table 17. Global Plasma Therapy Mergers & Acquisitions, Expansion Plans
    Table 18. Terumo Corporation Information
    Table 19. Terumo Description and Business Overview
    Table 20. Terumo Plasma Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 21. Terumo Plasma Therapy Product
    Table 22. Terumo Plasma Therapy Revenue Proportion of Plasma Therapy by Product in 2021
    Table 23. Terumo Plasma Therapy Revenue Proportion of Plasma Therapy by Application in 2021
    Table 24. Terumo Plasma Therapy Revenue Proportion of Plasma Therapy by Geographic Area in 2021
    Table 25. Terumo Recent Development
    Table 26. Arthrex Corporation Information
    Table 27. Arthrex Description and Business Overview
    Table 28. Arthrex Plasma Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 29. Arthrex Plasma Therapy Product
    Table 30. Arthrex Plasma Therapy Revenue Proportion of Plasma Therapy by Product in 2021
    Table 31. Arthrex Plasma Therapy Revenue Proportion of Plasma Therapy by Application in 2021
    Table 32. Arthrex Plasma Therapy Revenue Proportion of Plasma Therapy by Geographic Area in 2021
    Table 33. Arthrex Recent Development
    Table 34. Zimmer Biomet Corporation Information
    Table 35. Zimmer Biomet Description and Business Overview
    Table 36. Zimmer Biomet Plasma Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 37. Zimmer Biomet Plasma Therapy Product
    Table 38. Zimmer Biomet Plasma Therapy Revenue Proportion of Plasma Therapy by Product in 2021
    Table 39. Zimmer Biomet Plasma Therapy Revenue Proportion of Plasma Therapy by Application in 2021
    Table 40. Zimmer Biomet Plasma Therapy Revenue Proportion of Plasma Therapy by Geographic Area in 2021
    Table 41. Zimmer Biomet Recent Development
    Table 42. DePuy Synthes Corporation Information
    Table 43. DePuy Synthes Description and Business Overview
    Table 44. DePuy Synthes Plasma Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 45. DePuy Synthes Plasma Therapy Product
    Table 46. DePuy Synthes Plasma Therapy Revenue Proportion of Plasma Therapy by Product in 2021
    Table 47. DePuy Synthes Plasma Therapy Revenue Proportion of Plasma Therapy by Application in 2021
    Table 48. DePuy Synthes Plasma Therapy Revenue Proportion of Plasma Therapy by Geographic Area in 2021
    Table 49. DePuy Synthes Recent Development
    Table 50. EmCyte Corporation Information
    Table 51. EmCyte Description and Business Overview
    Table 52. EmCyte Plasma Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 53. EmCyte Plasma Therapy Product
    Table 54. EmCyte Plasma Therapy Revenue Proportion of Plasma Therapy by Product in 2021
    Table 55. EmCyte Plasma Therapy Revenue Proportion of Plasma Therapy by Application in 2021
    Table 56. EmCyte Plasma Therapy Revenue Proportion of Plasma Therapy by Geographic Area in 2021
    Table 57. EmCyte Recent Development
    Table 58. Regen Lab Corporation Information
    Table 59. Regen Lab Description and Business Overview
    Table 60. Regen Lab Plasma Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 61. Regen Lab Plasma Therapy Product
    Table 62. Regen Lab Plasma Therapy Revenue Proportion of Plasma Therapy by Product in 2021
    Table 63. Regen Lab Plasma Therapy Revenue Proportion of Plasma Therapy by Application in 2021
    Table 64. Regen Lab Plasma Therapy Revenue Proportion of Plasma Therapy by Geographic Area in 2021
    Table 65. ISTO Biologics Corporation Information
    Table 66. ISTO Biologics Description and Business Overview
    Table 67. ISTO Biologics Plasma Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 68. ISTO Biologics Plasma Therapy Product
    Table 69. ISTO Biologics Plasma Therapy Revenue Proportion of Plasma Therapy by Product in 2021
    Table 70. ISTO Biologics Plasma Therapy Revenue Proportion of Plasma Therapy by Application in 2021
    Table 71. ISTO Biologics Plasma Therapy Revenue Proportion of Plasma Therapy by Geographic Area in 2021
    Table 72. Cesca Therapeutics Corporation Information
    Table 73. Cesca Therapeutics Description and Business Overview
    Table 74. Cesca Therapeutics Plasma Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 75. Cesca Therapeutics Plasma Therapy Product
    Table 76. Cesca Therapeutics Plasma Therapy Revenue Proportion of Plasma Therapy by Product in 2021
    Table 77. Cesca Therapeutics Plasma Therapy Revenue Proportion of Plasma Therapy by Application in 2021
    Table 78. Cesca Therapeutics Plasma Therapy Revenue Proportion of Plasma Therapy by Geographic Area in 2021
    Table 79. Weigao Corporation Information
    Table 80. Weigao Description and Business Overview
    Table 81. Weigao Plasma Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 82. Weigao Plasma Therapy Product
    Table 83. Weigao Plasma Therapy Revenue Proportion of Plasma Therapy by Product in 2021
    Table 84. Weigao Plasma Therapy Revenue Proportion of Plasma Therapy by Application in 2021
    Table 85. Weigao Plasma Therapy Revenue Proportion of Plasma Therapy by Geographic Area in 2021
    Table 86. REV-MED Corporation Information
    Table 87. REV-MED Description and Business Overview
    Table 88. REV-MED Plasma Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 89. REV-MED Plasma Therapy Product
    Table 90. REV-MED Plasma Therapy Revenue Proportion of Plasma Therapy by Product in 2021
    Table 91. REV-MED Plasma Therapy Revenue Proportion of Plasma Therapy by Application in 2021
    Table 92. REV-MED Plasma Therapy Revenue Proportion of Plasma Therapy by Geographic Area in 2021
    Table 93. Nuo Therapeutics Corporation Information
    Table 94. Nuo Therapeutics Description and Business Overview
    Table 95. Nuo Therapeutics Plasma Therapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 96. Nuo Therapeutics Plasma Therapy Product
    Table 97. Nuo Therapeutics Plasma Therapy Revenue Proportion of Plasma Therapy by Product in 2021
    Table 98. Nuo Therapeutics Plasma Therapy Revenue Proportion of Plasma Therapy by Application in 2021
    Table 99. Nuo Therapeutics Plasma Therapy Revenue Proportion of Plasma Therapy by Geographic Area in 2021
    Table 100. Global Plasma Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 101. Global Plasma Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Global Plasma Therapy Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 103. North America Plasma Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 104. North America Plasma Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 105. North America Plasma Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 106. North America Plasma Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 107. Asia-Pacific Plasma Therapy Revenue by Region (2017-2028) & (US$ Million)
    Table 108. Asia-Pacific Plasma Therapy Revenue by Region (2023-2028) & (US$ Million)
    Table 109. Asia-Pacific Plasma Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 110. Asia-Pacific Plasma Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 111. Europe Plasma Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 112. Europe Plasma Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 113. Europe Plasma Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 114. Europe Plasma Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 115. Latin America Plasma Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 116. Latin America Plasma Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 117. Latin America Plasma Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 118. Latin America Plasma Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 119. Middle East and Africa Plasma Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 120. Middle East and Africa Plasma Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 121. Middle East and Africa Plasma Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 122. Middle East and Africa Plasma Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 123. Plasma Therapy Key Raw Materials, Industry Status and Trend
    Table 124. Plasma Therapy Key Raw Materials and Upstream Suppliers
    Table 125. Plasma Therapy Clients Status and Trend
    Table 126. Plasma Therapy Typical Clients
    Table 127. Plasma Therapy Distributors
    Table 128. Plasma Therapy Market Trends
    Table 129. Plasma Therapy Market Drivers
    Table 130. Plasma Therapy Market Challenges
    Table 131. Plasma Therapy Market Restraints
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Plasma Therapy Product Picture
    Figure 2. Global Plasma Therapy Revenue Market Share by Type in 2021 & 2028
    Figure 3. Pure PRP Product Picture
    Figure 4. Leucocyte-rich PRP Product Picture
    Figure 5. Leukocyte-rich Fibrin (L-PRF) Product Picture
    Figure 6. Global Plasma Therapy Revenue Market Share by Application in 2021 & 2028
    Figure 7. Orthopedic
    Figure 8. Darmatology
    Figure 9. Cardiac Muscle Injury
    Figure 10. Dental
    Figure 11. Nerve Injury
    Figure 12. Plasma Therapy Report Years Considered
    Figure 13. Global Plasma Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Plasma Therapy Market Size 2017-2028 (US$ Million)
    Figure 15. Global Plasma Therapy Market Size Market Share by Region: 2022 Versus 2028
    Figure 16. Global Plasma Therapy Revenue Market Share by Region (2017-2028)
    Figure 17. Plasma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Plasma Therapy Revenue Market Share Forecast by Type (2017-2028)
    Figure 19. Global Plasma Therapy Revenue Market Share Forecast by Application (2017-2028)
    Figure 20. North America Plasma Therapy Revenue 2017-2028 (US$ Million)
    Figure 21. North America Plasma Therapy Revenue Market Share by Type (2017-2022)
    Figure 22. North America Plasma Therapy Revenue Market Share by Application (2017-2022)
    Figure 23. Asia-Pacific Plasma Therapy Revenue 2017-2028 (US$ Million)
    Figure 24. Asia-Pacific Plasma Therapy Revenue Market Share by Region (2017-2028)
    Figure 25. Asia-Pacific Plasma Therapy Revenue Market Share by Type (2017-2022)
    Figure 26. Asia-Pacific Plasma Therapy Revenue Market Share by Application (2017-2022)
    Figure 27. Europe Plasma Therapy Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 28. Europe Plasma Therapy Revenue Market Share by Country (2017-2028)
    Figure 29. Europe Plasma Therapy Revenue Market Share by Type (2017-2022)
    Figure 30. Europe Plasma Therapy Revenue Market Share by Application (2017-2022)
    Figure 31. Latin America Plasma Therapy Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 32. Latin America Plasma Therapy Revenue Market Share by Country (2017-2022)
    Figure 33. Latin America Plasma Therapy Revenue Market Share by Type (2017-2022)
    Figure 34. Latin America Plasma Therapy Revenue Market Share by Application (2017-2022)
    Figure 35. Middle East and Africa Plasma Therapy Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 36. Middle East and Africa Plasma Therapy Revenue Market Share by Country (2017-2028)
    Figure 37. Middle East and Africa Plasma Therapy Revenue Market Share by Type (2017-2022)
    Figure 38. Middle East and Africa Plasma Therapy Revenue Market Share by Application (2017-2022)
    Figure 39. Plasma Therapy Supply Chain (Upstream and Downstream Market)
    Figure 40. Global Production Market Share of Plasma Therapy Raw Materials by Region in 2021
    Figure 41. Plasma Therapy Distribution Channels
    Figure 42. Global Plasma Therapy Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 43. Global Plasma Therapy Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 44. Bottom-up and Top-down Approaches for This Report
    Figure 45. Data Triangulation
    Figure 46. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners
SIMILAR REPORTS